The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in income, its intellectual property lapse created a flood of lower-priced alternatives , significantly eroding its position . While specific pharmaceutical companies may try to click here capitalize on s